[Form 4] Revvity, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Revvity, Inc. (RVTY) reporting person Maxwell Krakowiak, identified as Senior Vice President and Chief Financial Officer, acquired a non-qualified stock option on 08/15/2025. The grant covers 44,446 options with an exercise price of $90.465. The filing states the option is scheduled to fully vest on the third anniversary of the grant date and has a 7-year term. The Form 4 was submitted by a power-of-attorney signature (/s/ John L. Healy) on 08/18/2025. The report does not disclose other holdings, cash proceeds, or related transactions.

Insights

Financial Analyst

TL;DR: Routine executive equity grant to the CFO of 44,446 NQ options at a $90.465 strike; standard vesting and term.

The Form 4 documents a single equity compensation event: a non-qualified stock option award to Maxwell Krakowiak dated 08/15/2025 for 44,446 options at a $90.465 exercise price. The filing specifically states the option fully vests on the third anniversary of the grant and carries a seven-year term. This is a targeted disclosure of insider compensation and does not include additional transactions or changes in direct beneficial ownership beyond the granted options. Impact is routine from a financial reporting perspective.

Corporate Governance Expert

TL;DR: Governance disclosure is complete for this grant: reporting person, role, grant specifics, vesting schedule, and POA signature are provided.

The Form 4 identifies the reporting person, relationship to the issuer (Senior VP & CFO), the exact number of options (44,446), strike price ($90.465), grant date (08/15/2025), vesting schedule (fully vests on third anniversary), and term (7 years). The filing was signed by an authorized POA on 08/18/2025. The disclosure meets Section 16(a) reporting requirements for this transaction; no additional governance issues are disclosed in the text.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Krakowiak Maxwell

(Last) (First) (Middle)

77 4TH AVENUE

(Street)

WALTHAM MA 02451-7567

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
REVVITY, INC. [ RVTY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Please See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
NQ Stock Option (right to buy)	$90.465	08/15/2025		A		44,446		(1)	08/15/2032	Common Stock	44,446	$0	44,446	D

Explanation of Responses:

1. This option is scheduled to fully vest on the third anniversary of the date of grant and has a 7-year term.

Remarks:

Senior Vice President and Chief Financial Officer

	/s/ John L. Healy (POA on file) for Maxwell Krakowiak	08/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Maxwell Krakowiak report on Form 4 for RVTY?

The Form 4 reports the acquisition of a non-qualified stock option for 44,446 shares with an exercise price of $90.465, dated 08/15/2025.

What is the vesting schedule and term for the options granted to the CFO (RVTY)?

The filing states the option is scheduled to fully vest on the third anniversary of the grant date and has a 7-year term.

Who signed the Form 4 for Maxwell Krakowiak and when was it filed?

The Form 4 was signed by /s/ John L. Healy (POA on file) and dated 08/18/2025.

What is Maxwell Krakowiak's role at Revvity disclosed in the filing?

The filing identifies Maxwell Krakowiak as Senior Vice President and Chief Financial Officer of Revvity, Inc.

Does the Form 4 disclose any other securities or dispositions for the reporting person?

No. The Form 4 contains a single reported transaction for the non-qualified stock option and does not disclose other acquisitions or dispositions.